Literatur
Cöster L, Kendall S, Gerdle B et al. (2008) Chronic widespread musculoskeletal pain – a comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain 12: 600–610
Eich W, Häuser W, Friedel E et al. (2008) Definition, Klassifikation und Diagnose von chronischen Schmerzen in mehreren Körperregionen und des Fibromyalgiesyndroms. Schmerz 22: 255–266
MacFarlane G, Morris G, Hunt M et al. (1999) Chronic widespread pain in the community: the influence of psychologcial symptoms and mental disorder on healthcare seeking behavior. J Rheumatol 26: 413–419
Schiltenwolf M, Eich W, Schmale-Grete R, Häuser W (2008) Ziele der Leitlinie zur Diagnostik und Therapie des Fibromyalgiesyndroms. Schmerz 22: 241–243
White KP, Nielson WR, Harth M et al. (2002) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29(3): 588–594
Wolfe F (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56: 268–271
Interessenkonflikt
H. Hardinghaus: Keine Angabe
W. Häuser: Referentenhonorare für Janssen-Cilag, Lilly, Mundipharma, Pfizer
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hardinghaus, W. AWMF-Leitlinie „Fibromyalgiesyndrom“. Schmerz 22, 682–684 (2008). https://doi.org/10.1007/s00482-008-0725-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00482-008-0725-x